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Abstract Numerous steroids are essential plant, animal, and
human hormones. The medical and industrial applications of
these hormones require the identification of new synthetic
routes, including biotransformations. The metabolic fate of a
steroid can be complicated; it may be transformed into a vari-
ety of substituted derivatives. This may be because a steroid
molecule can adopt several possible orientations in the bind-
ing pocket of a receptor or an enzyme. The present study,
based on docking and molecular dynamics, shows that it is
indeed possible for a steroid molecule to bind to a receptor
binding site in two or more orientations (normal, head-to-tail
reversed, upside down). Three steroids were considered: pro-
gesterone, dehydroepiandrosterone, and 7-oxo-dehydroepian-
drosterone. Two proteins were employed as hosts: the human
mineralocorticoid receptor and a bacterial Baeyer–Villiger
monooxygenase. When the steroids were in nonstandard ori-
entations, the estimated binding strength was found to be only
moderately diminished and the network of hydrogen bonds
between the steroid and the host was preserved.
Keywords Steroids .Progesterone .DHEA .Baeyer–Villiger
monooxygenase .Molecular docking .Molecular dynamics
Introduction
Steroid hormones and their derivatives form a large group of
useful pharmaceutical preparations that are employed in the pre-
vention and treatment of diverse diseases in gynecology, endo-
crinology, rheumatology,oncology, etc.Theyareusedmedically
and industrially because numerous steroids are essential plant,
animal, and human hormones. Compounds such as hydrocorti-
sone, dehydroepiandrosterone (DHEA), and prednisolone are
among the best-known steroid drugs and food additives.
Brassinosteroids (plant growth factors) are used to boost crop
yields [1]. Medical and industrial applications of this class of
compounds require the identification of new synthetic routes,
preferably using cheap starting materials (e.g., phytosterols).
Such routes include biotransformations, which are ecologically
friendlierandmorestereospecific syntheticpathways thanchem-
ical derivatization [2]. However, it is not easy to predict which
particular derivatives can be obtained using bacterial or fungal
organisms, or even whether a particular species of microorgan-
ism can transform an available substrate at all. Moreover, the
metabolic fate of steroids is frequently found to be complicated:
a given compound can be transformed into a variety of substitut-
ed derivatives. For example, the biotransformation of pregneno-
lone in cultures of the filamentous fungus Penicillium
camemberti AM83 yields five different derivatives, including
progesterone, androstenedione, and dehydroepiandrosterone
(DHEA) [3]. The diversity of the metabolic routes of steroids
indicates that theyare transformedbyseveralgroupsofenzymes.
The conversion of cholesterol byMycobacterium sp. Ac-1815D
leads to at least six products; the enzymes involved are 3β-
hydroxysteroid and 3(17)-hydroxysteroid dehydrogenases, 3-
ketosteroid 1,2-dehydrogenase, and side-chain degradation en-
zymes[4].Side-chaindegradation involves fourgroupsof induc-
ible enzymes: the fatty acid β-oxidation, ω-oxidase reaction,
methyl-crotonyl-CoA carboxylation, and propionyl-CoA
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carboylase systems [5]. However, in some caseswhere only one
enzymeappears tobe involved, analternative explanation for the
diversity of steroid derivatives has been suggested.An extensive
studyon transformationsofacetylaminosteroids [6] revealed that
somehydroxylationscarriedoutbythefungusCurvularia lunata
can be rationalized by assuming that the steroid molecule can
adopt several possible orientations in the enzymatic binding
pocket. The idea that a steroid ligand can adoptmultiple orienta-
tions inabindingpocketwasinvestigated in1967inastudyof the
steroid conversion capabilities of Aspergillus tamarii [7], where
at least four such orientations were proposed. This mechanism
can also partially account for the broad range of reactions carried
out by one of most popular whole-cell fungal biocatalysts,
Rhizopus oryzae [8].A simplemechanisticmodel of the relevant
cytochrome P450 monooxygenase was proposed: an irregular
polyhedron containing two hydrophilic patches [8, 9].
Recently,11α-hydroxylaseofR.oryzaewasexpressed in recom-
binant yeast and used in its pure form to transform progesterone,
testosterone, 11-deoxycorticosterone, and 11-deoxycortisol into
varying amounts of 11α-hydroxyprogesterone and 6β-
hydroxyprogesterone [10]. This result provides strong support
for theBoneenzyme,multiplesubstrateorientations^hypothesis.
Stereochemical restrictions were also invoked to rationalize the
diverse metabolites of steroids in cultures ofAspergillus tamarii
[11–13]. Our studies indicated that this mechanism may also
occur in steroid hydroxylation reactions carried out by cultures
of the filamentous fungi Beauveria bassiana, Absidia coerulea,
andMortierella isabellina [14–16].
Our knowledge of the diversity of metabolic routes of ste-
roids is not, however, complemented by a deep understanding
of enzymatic mechanisms of action on steroid substrates. In
particular, structural information on the relevant enzymes is
scarce. There are only a few reports in the Protein Data Bank
(PDB) on crystal structures of bacterial Baeyer–Villiger
monooxygenases (BVMOs) or dehydrogenases [17–21], and
only a fraction of those relate to enzymatic action on steroids
[17, 18]. The first structural report on fungal BVMO appeared
in mid-2016 [22], and describes an enzyme from Aspergillus
flavus that converts alkanones and aryl ketones to esters; its
activity towards cyclic ketones is much lower. On the other
hand, mammalian steroid receptors have received some atten-
tion from researchers, which has resulted in the characteriza-
tion of the hydrogen-bonding network that allows the binding
of steroids by the human mineralocorticoid receptor (MR)
protein NR3C2 [23], for example.
Our interest in the substrate specificity of enzymes acting
on steroids prompted us to carry out the study reported in the
present paper, which tackled the subject using docking and all-
atom molecular dynamics (MD). We chose to investigate the
orientational versatility of steroidal ligands in the binding
pockets of two proteins: the human mineralocorticoid receptor
MR [23] and the bacterial BVMO from Rhodococcus
rhodochrous [17]. The selected ligands were progesterone
(an important hormone that was experimentally found to bind
strongly to the MR and was transformed by the chosen
BVMO) as well as DHEA together with its 7-oxo derivative
(see Fig. 1); the latter two ligands are of special interest to us
(we have already studied them in previous investigations [3,
24]). In the following, we report on the docked structures of
these three steroid ligands, their relative energies (scoring
functions), as well as the dynamic behavior of the steroids in
the binding pockets of the receptors.
Methods
The initial structures of the proteins were taken from the PDB
repository [25]; the structural entries 2AA5 (for theMRprotein
[23]; this contains progesterone as the ligand) and 4AOS (for
the steroidal BVMO [17]; loaded with cofactors only, not the
steroid substrate) were used. The residue numbers stated sub-
sequently in this paper correspond to the numbering schemes
used for the PDB entries. The files were manually edited to
remove duplicate atoms resulting from crystal disorder, and
only one chain of the dimeric 2AA5 structure was retained.
The structures of the three ligands (see Fig. 1) were based on
the progesterone skeleton of the MR–steroid complex 2AA5.
After performing chemical modifications, the relevant hydro-
gen atoms were added and the structures were optimized at the
semiempirical AM1 level. Further, the topology and parameter
files were generated for the ligands with the GAFF force field
[26], and theatomicchargeswereparameterizedwith theAM1-
BCC scheme. This part of the study as well as the subsequent
molecular dynamics simulations were carried out with the
AMBER14 +AmberTools 2015 suite [27].
Fig. 1 Structures of the steroids
used as ligands in this work. The
atom numbering scheme and
labels A–D for the rings of the
steroid nucleus are shown for
progesterone
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Docking simulations were performed with the Autodock
Vina 1.1.2 package [28]. For the MR protein, the center of
the cubic docking box was placed at the barycenter of the
ligand, and the box edge was set to 24 Å, meaning that the
box covered ca. 75% of the volume of the single protein sub-
unit. For the BVMO (for which the ligand was not included in
the crystal), the center was placed at the barycenter of the
protein, close to the estimated binding site and the NADP
and FAD cofactors, and the box edge was set to 48Å,meaning
that the box included all of the protein. The docking runs were
repeated five times for each of the six protein–ligand pairs.
For the MR protein (for which the exact ligand position
was known), a full-atom molecular dynamics simulation was
carried out. The aim was to reproduce the dynamics of the
ligand within the protein, so the simulation length scale was
adapted to the dynamics of the hydrogen-bond network rather
than to the protein relaxation times. The initial structures were
the structures with docked ligands.
In the first step, using the utilities package in
AmberTools 2015, hydrogen atoms and missing heavy
atoms were added to the structure of the monomeric pro-
tein. The protein–ligand complex was then immersed in a
rectangular box of TIP3P water with a 12-Å buffer, and
three Na+ ions were added at the locations of minimum
electrostatic potential to ensure neutrality. The force fields
used for the ligand and the protein were GAFF [26] and
ff14SB [29], respectively. The simulation then progressed
as follows: 1000 steps of steepest-descent energy minimi-
zation were performed to remove bad contacts before 30 ps
of NVT thermalization and 70 ps of NPT equilibration (T =
300 K, p = 1 atm) were carried out. The production run was
1 ns of NVT simulation. A 1-fs timestep was used consis-
tently to propagate the nuclear degrees of freedom. The
particle mesh Ewald technique was used for electrostatic
summations, and the direct space nonbonded cutoff was set
to 12 Å. Bonds involving hydrogen atoms were restrained
with the SHAKE algorithm [30]. The MD runs were car-
ried out in triplicate for each binding mode found for a
given ligand (two for progesterone and three each for
DHEA and 7-oxo-DHEA), starting with different random
number seeds. No statistically significant differences were
observed among the triplicates performed for a given run.
These calculations performed with the AMBER14 suite
were followed by trajectory analysis. The VMD 1.9.1 pro-




We first attempted to dock the three steroids to the human
mineralocorticoid receptor NR3C2, because the exact position
of the steroid ligand at this receptor has already been deter-
mined experimentally [23]. Progesterone binds strongly to this
protein without triggering its regulatory activity [23]. The re-
peated docking runs always yielded the same two structures of
MR-docked progesterone, as depicted in Fig. 2. The best of
those structures (i.e., the structure with the highest affinity
score, −12.1 kcal/mol) corresponds to the experimental posi-
tion of the ligand; the root mean square deviation (RMSD)
between the experimental and best MR-docked position of
progesterone is 0.23 Å. For DHEA and 7-oxo-DHEA, the best
docked structures are again very similar to the experimental
orientation of progesterone; the corresponding RMSD (calcu-
lated for the steroid nucleus atoms only) is 0.39 Å for both
DHEA and 7-oxo-DHEA. Some of this increase in RMSD for
DHEA and 7-oxo-DHEA compared to progesterone can be
attributed to differences in the steroid nuclei of these ligands
(different locations of the double bond). However, the calcu-
lated affinities are smaller for DHEA and 7-oxo-DHEA:
−10.8 kcal/mol and −10.9 kcal/mol, respectively. The negligi-
ble difference in affinity between DHEA and its derivative
could be due to the weak interaction (3.4 Å) between the
carbonyl oxygen at C-7 of the ligand and the sulfur atom of
Met852 (as mentioned above, the residue labels follow the
original numbering schemes for the PDB entries). The loss
of affinity in comparison to progesterone is caused by the fact
that the side-chain oxygen atom of the latter forms a hydrogen
bond with Thr945–OH (2.72 Å), while the acetyl sidechain is
replaced with a keto function in DHEA and its derivative, and
the corresponding O···O distance increases to 3.8 Å. That said,
Fig. 2 Docking results for the MR protein and three steroid ligands. Oxygen atoms are represented as spheres; hydrogen atoms are omitted for clarity.
The labels on the oxygen atoms indicate the rank of the structure, 1 being the highest ranked (i.e., it shows the strongest affinity); see Table 1
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the primary binding mode is conserved for the three investi-
gated steroids.
It is important to note that other binding modes were located
by the docking procedure (see Fig. 2), and their calculated affin-
ities and orientations (see Table 1) follow an interesting pattern.
The orientations are labeled according to the ideas of Brannon
et al. [7] and Holland et al. [6]. We denote the highest-affinity
structure as the Bnormal^ (n) structure, which corresponds to the
experimentally observed structure docked to the MR protein.
When the steroid nucleus is docked such that the A and D rings
have switched positions with regard to the normal orientation, it
termed Breversed^ (r) binding. If the methyl groups at C-10 and
C-13 point in the opposite directions to their directions in the
normalcase,wedenote thisBinverted^ (i)binding.Finally, ifboth
reversed and invertedbindingoccur at the same time, the result is
Breverse inverted^ (ri) binding. In somecases, the angle between
the normal direction of the methyl groups and the considered
structure is closer to 90° than 180° and the rings are reversed,
leading to (r/ri) binding.
Continuing the discussion of the results obtained for the
MR protein, we note that only two orientations were found
for the progesterone ligand. The normal (experimental) one is
stabilized by two hydrogen bonds between the A-ring hydrox-
yl and the Arg81 amine nitrogen (2.80 Å) and between the D-
ring side-chain oxygen and the Thr203 hydroxyl (2.74 Å). In
the (r/ri) orientation, these contacts (now between the D-ring
side chain and Arg81 and between the A-ringOH and Thr203)
are, respectively, 3.92 Å and 2.80 Å long. The loss of the first
contact significantly worsens the affinity, so we would expect
the progesterone to bind to the MR protein in a specific ori-
entation. On the other hand, DHEA, which has no acetyl
sidechain but does have an oxo function at C-17, potentially
binds as strongly in all three modes. The preferred (n) mode
has close contacts with Arg81 (2.88 Å) and Gln40 (2.84 Å),
but the contact to Thr203 is lost (>4 Å). The (ri) mode regains
this contact (2.70 Å), as also does the (r/ri) mode (2.60 Å), but
these modes lose contact with Arg81. They do, however, re-
tain the hydrogen bonds to Gln40 (2.67 Å for (ri) and 3.37 Å
for (r/ri), making it the least preferred orientation). Thus,
DHEA probably binds in more than one preferred orientation.
Similar behavior is seen for 7-oxo-DHEA, but the two best
orientations, (n) and (ri), also form a short contact (3.3 Å) with
the sulfur atom of Met116. The mode with the lowest affinity
also lacks the contact with Thr203. The dynamic variability of
these contacts was subsequently investigated further by all-
atom MD. Here we conclude by stating that even relatively
small structural modifications (i.e., DHEA vs. 7-oxo-DHEA)
can influence the network of contacts formed and change
binding preferences.
In the case of the steroidal BVMO from Rhodococcus
rhodochrous [17], there is no reference experimentally derived
position of the steroid. However, the progesterone and DHEA
bind at the same location and with the same mode, whereas 7-
oxo-DHEAchooses the same locationbut the (r)orientationwith
respect to the other ligands (see Fig. 3). Thus, we chose to label
the orientations with respect to the best (n) docking results for
progesterone and DHEA. Note that the (n) binding mode of 7-
oxo-DHEA is only 0.2 kcal/mol worse than its best (r) mode, so
the ranking in this case is rather unclear. Indeed, this is a general
trend that started to emerge for the MR protein but is readily
apparent in the BVMO case: while progesterone has a preferen-
tial binding mode (n) and its other orientations are clearly less
preferred, theaffinitiesof thebindingmodesoccurwithinamuch
narrower range for both DHEA and its derivative: the best and
worst binding modes are separated by only 0.8 kcal/mol for
DHEAand just 0.5kcal/mol for 7-oxo-DHEA.This is consistent
withprevious reportson thediversityof theproductsofenzymat-
ic transformations of steroids [10–16].
The steroids bind to the BVMO loaded with NADP and
FAD cofactors through the following contacts observed for
the best binding modes. Progesterone in its (n) orientation
forms hydrogen bonds to Ser54–OH (3.10 Å) and Tyr61–
OH (3.08 Å) via its acetyl oxygen function. Additional stabi-
lization is gained through a hydrophobic interaction with
Trp62. Longer, weaker contacts (>4 Å) are formed with
Arg123, Asn160, and His184, as well as with the FAD cofac-
tor. The DHEA molecule in its (n) orientation retains the hy-
drophobic interaction and the contacts with Tyr61 (3.85 Å),
Arg123, Asn160, and His184; a contact with Lys404–NH3
+
(3.86 Å) is also formed. The 7-oxo-DHEA molecule is also
oriented parallel to the Trp62 residue, and it forms hydrogen
bonds to Asn160 (3.19 and 3.36 Å), the Ala53 backbone N
Table 1 Binding affinities (in
kcal/mol) and orientations of the
binding modes of progesterone,
DHEA, and 7-oxo-DHEA to the
two studied proteins (MR NR3C2
and steroid BVMO)
Protein MR NR3C2 Steroid BVMO
Ligand Progesterone DHEA 7-Oxo-DHEA Progesterone DHEA 7-Oxo-DHEA
Rank 1 −12.1 (n) −10.8 (n) −10.9 (n) −8.6 (n) −7.9 (n) −7.8 (r)
Rank 2 −8.9 (r/ri) −9.1 (ri) −9.2 (ri) −7.3 (r) −7.8 (r) −7.6 (n)
Rank 3 – −9.0 (r/ri) −8.4 (i) −6.9 (i) −7.4 (i) −7.3 (ri)
Rank 4 – – – – −7.1 (ri) −7.3 (i)
The ranks of the docked structures correspond to the labeling in Fig. 2 for MR NR3C2. Orientation codes: (n)
normal, (r) reverse, (i) inverted, (ri) reverse inverted (see text for details). Results are from Vina docking runs
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(3.27 Å), and the FAD cofactor (3.04 Å). The latter two bonds
involve the 7-keto oxygen atom and may be responsible for
the small preference for the (r) orientation over the (n) one.
Summarizing the results of the docking study, it is clear that
DHEA and 7-oxo-DHEA are both more flexible ligands than
progesterone (this behavior was observed with both of the
investigated proteins). Especially for the steroid BVMO, a
mixture of oxidation products should be expected. However,
docking presents a simplified and static picture. Therefore, we
followed the docking study with an investigation of the dy-
namics of the steroid–host contacts.
Molecular dynamics simulations
ThemineralocorticoidreceptorNR3C2wasfoundinthedocking
study to bind progesterone preferentially in one orientation. The
affinity of the preferred orientation is 3.2 kcal/mol higher than
that of the other binding mode identified in the docking study.
However, thedifferences inbinding-modeaffinityaresmaller for
DHEA and 7-oxo-DHEA, and these ligands can adopt three ori-
entations, although the best orientation is consistent with that for
progesterone. These facts are reflected in the dynamics of the
hydrogen-bonding network around the ligand. The steroids con-
sidered here possess up to three oxygen functions (see Fig. 1),
namely those at C-3, at C-17 (or the C-17 side chain), and at C-7
(7-oxo-DHEA only). Due to the large number of possible con-
tacts, we initially chose to represent the results of theMD simu-
lations in the formofradialdistributionfunctions (RDFs),andwe
later complemented those RDFswith a hydrogen-bonding anal-
ysis. For each of the ligand oxygen atoms, two such RDFs were
calculated, relating to contactswith protein oxygen and nitrogen
atoms. The results are shown in Fig. 4.
Comparison of the results for the best (rank 1) Bnormal^
orientations of progesterone, DHEA, and 7-oxo-DHEA shows
differences between their hydrogen-bonding networks, which
are due to differences in the nature of the oxygen function at
C-3: this is a carbonyl oxygen for progesterone and a hydroxyl
function for DHEA and its derivative. The C-3 carbonyl oxy-
gen atom in progesterone prefers to form contacts with protein
nitrogen atoms (RDF maximum at 2.85 Å), while there are
contacts with both oxygen (2.70–2.75 Å) and nitrogen
(2.95 Å) atoms for the other two steroids. While it is true that
O···N hydrogen bonds are generally weaker than their O···O
analogs [32], in this case there are charge-assisted hydrogen
bonds with charged amino functions of arginine. Continuing
the discussion of the (n) orientation (rank 1), we note that—
contrary to the docking result—the difference between the C-
17 substituents (acetyl in progesterone and carbonyl oxygen in
DHEA and 7-oxo-DHEA) does not lead to differences in the
distance of the contact with the oxygen at C-17/side chain.
The corresponding RDFs are similar and show maxima at
2.7–2.9 Å. This is another manifestation of the adaptability
of various steroids to binding pockets.
When less stable binding modes are considered, there are
two possible cases. First, the rotated steroid molecule can lose
its most important contacts. This is the case for the (r/ri) ori-
entation of progesterone (rank 2), which loses interactions
with nitrogen atoms. Even though the carbonyl oxygen at C-
3 assumes the role of the acetyl oxygen in the (n) orientation
(sharp maximum in the O···O RDF close to 2.7 Å), the acetyl
oxygen of the rank-2 structure has its RDF maxima at dis-
tances larger than 3 Å. Thus, the (r/ri) orientation for proges-
terone is significantly destabilized. The same holds for the
rank-3 structure (r/ri) of DHEA, for which the oxo function
at C-17 has no hydrogen-bonded contacts. A second type of
behavior occurs for the rank-2 structure of DHEA (ri) and the
rank-3 structure of 7-oxo-DHEA (i). In these cases, the oxy-
gen atoms are able to assume the roles of their counterparts in
the Bnormal^ rank-1 structure. Compare, for example, the
RDFs for the rank-1 and rank-2 structures of DHEA.
Contact with nitrogen atoms at 2.95 Å is present for the C-3
hydroxyl and carbonyl oxygen atoms in the rank-1 and rank-2
structures, respectively. Contact with oxygen atoms at 2.70–
2.75 Å is present for the C-17 carbonyl and C-3 hydroxyl
oxygen atoms in the rank-1 and rank-2 structures, respective-
ly. The rank-2 (ri) structure of 7-oxo-DHEA lies between the
two behavioral types described above: while its C-17 carbonyl
oxygen does not form short contacts (<3 Å), its C-7 oxo func-
tion interacts much more strongly with protein oxygen atoms
than does the C-7 oxygen in the rank-1 structure.
RDF analysis is not able to differentiate clearly between
hydrogen bonds and short electrostatic contacts. Hydrogen
bonds are, however, regarded as the tools that enzymes use
to activate substrates [33]. It is generally accepted that low-
barrier hydrogen bonds (LBHBs) are formed as an enzyme’s
substrate approaches the transition structure [33]. However,
the NR3C2 protein is a steroid receptor, not an enzyme, so it
Fig. 3 Best binding modes of the three steroid ligands within the
steroidal BVMO. Oxygen atoms are represented as spheres; hydrogen
atoms are omitted for clarity
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does not require strong, short hydrogen bonds to form be-
tween the substrate and the host. Indeed, the distances of the
contacts located in the RDFs are mostly within 2.7–3.0 Å.
However, as this study was intended to initiate further com-
putational research by us in the field of steroid enzymatic
catalysis, we chose to proceed with a more detailed analysis
of the hydrogen bonds along the MD trajectory. Numerous
indicators of the hydrogen bonding have been proposed, but
geometric criteria are the most practical for structural protein
research. Commonly, a donor–acceptor cutoff of ca. 3.0 Å,
based on the sum of the van der Waals radii [34], is used to
detect O···O hydrogen bonds in small-molecule X-ray diffrac-
tometry. Much more relaxed criteria have been proposed for
experimental studies on proteins, including r(D···A) < 3.9 Å
Fig. 4 Radial distribution
functions (RDFs) for the
indicated oxygen atoms of the
steroid ligands (results from MD
simulation). Chart axes: x-axis is
the O···O/O···N distance in Å; y-
axis is the normalized RDF in
units of Å−1. Thick lines show
O···O RDFs and thin lines show
O····N RDFs. The percentages
refer to populations of the
hydrogen bonds (O···O and O···N
combined) between the steroid
oxygen function and the protein
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and ∠(D–H···A) > 90° [35]. This relaxation of the criteria
arises, at least partially, from the fact that an enzyme can
undergo large structural changes when it is in action (see
[36] for a recent example), and the network of hydrogen bonds
also strongly fluctuates. Considering the dynamic nature of
the contacts formed, we finally chose to use rather conserva-
tive values to define the occurrence of hydrogen bonding:
r(D···A) < 3.3 Å and ∠(D–H···A) > 135°. Proper care was tak-
en to treat steroid oxygen functions as either acceptors only
(keto function) or possible donors and acceptors (hydroxyl
function). The hydrogen-bond populations (the percentage
of the MD trajectory that satisfies the abovementioned
criteria) for the oxygen functions of the steroids are indicated
in Fig. 4. It is noticeable that the best (rank-1) binding modes
are associated with the largest populations for all three of the
investigated ligands. Comparison with the RDF results shows
that there are cases with short contacts that are not regarded as
hydrogen bonds, especially for the keto function at C-7 in 7-
oxo-DHEA. These correspond to contacts between two sites
that cannot act as donors (e.g., the keto function of the steroid
and the carbonyl function of the protein backbone). The flex-
ibility of steroids as ligands is clearly demonstrated byDHEA,
as the rank-1 and rank-2 binding modes are characterized by
virtually identical hydrogen-bond populations. Comparison of
the RDFs shows that the secondary interaction switches from
the O···O (64% population) to the O···N (66% pop.) type.
The above discussion of the MD results focused on hydro-
gen bonding and electrostatic contacts. This was done to ra-
tionalize the possibility that the hydrogen-bonding network is
preserved to some extent in the inverted and reversed binding
modes. Also, the presence of sharp maxima indicates that the
steroid ligands do not reorient in the binding pocket on the
investigated timescale. Note that, since we did not calculate
the MD-based free energies of binding, we were not able to
compare the docking results with the MD results directly. An
interesting case could be the rank-3 structure of 7-oxo-DHEA.
Although it is the worst structure identified by docking, it
seems to have a comparable hydrogen-bonding network to
the rank-1 binding mode. Therefore, we are currently carrying
out a detailed MD study of the behavior of DHEA and its
derivatives in the MR protein and in the BVMO enzyme.
Conclusions
Recent advances in structural studies of steroid-binding pro-
teins—including a notable increase in the number of known
3D structures of steroid–protein complexes—have resulted in
the possibility of investigating the behavior of steroid ligands
through mechanistic simulation. The results of the combined
docking and molecular dynamics study of three steroids
bound to two different proteins (a mineralocorticoid receptor
and a bacterial monooxidase) performed in this work fully
support the notion that bound steroidal ligands possess con-
siderable orientational versatility. At least two binding modes
were found for each steroid studied in this work, and their
affinities do not differ dramatically. Moreover, the MD study
of the MR protein indicated that changes in orientation do not
automatically result in serious disruption of the hydrogen-
bonding network stabilizing the ligand. Especially for
DHEA and 7-oxo-DHEA, the oxygen functions were found
to be adaptable in terms of their intermolecular contacts. This
adaptability was less visible for progesterone. Our study thus
provides computational support for a possible explanation for
the diversity of products of enzymatic transformations of ste-
roid substrates.
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